Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum hepatitis B surface antigen correlates with fibrosis and necroinflammation: A multicentre perspective in China.
Zhang P, Du HB, Tong GD, Li XK, Sun XH, Chi XL, Xing YF, Zhou ZH, Li Q, Chen B, Wang H, Wang L, Jin H, Mao DW, Wang XB, Wu QK, Li FP, Hu XY, Lu BJ, Yang ZY, Zhang MX, Shi WB, He Q, Li Y, Jiang KP, Xue JD, Li XD, Jiang JM, Lu W, Tian GJ, Hu ZB, Guo JC, Li CZ, Deng X, Luo XL, Li FY, Zhang XW, Zheng YJ, Zhao G, Wang LC, Wu JH, Guo H, Mi YQ, Gong ZJ, Wang CB, Jiang F, Guo P, Yang XZ, Shi WQ, Yang HZ, Zhou Y, Sun NN, Jiao YT, Gao YQ, Zhou DQ, Ye YA. Zhang P, et al. Among authors: zhang mx, zhang xw. J Viral Hepat. 2018 Sep;25(9):1017-1025. doi: 10.1111/jvh.12903. Epub 2018 May 11. J Viral Hepat. 2018. PMID: 29624802 Clinical Trial.
[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].
Hou FQ, Yin YL, Zeng LY, Shang J, Gong GZ, Pan C, Zhang MX, Yin CB, Xie Q, Peng YZ, Chen SJ, Mao Q, Chen YP, Mao QG, Zhang DZ, Han T, Wang MR, Zhao W, Liu JJ, Han Y, Zhao LF, Luo GH, Zhang JM, Peng J, Tan DM, Li ZW, Tang H, Wang H, Zhang YX, Li J, Zhang LL, Chen L, Jia JD, Chen CW, Zhen Z, Li BS, Niu JQ, Meng QH, Yuan H, Sun YT, Li SC, Sheng JF, Cheng J, Sun L, Wang GQ. Hou FQ, et al. Among authors: zhang dz, zhang mx, zhang yx, zhang jm, zhang ll. Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):589-596. doi: 10.3760/cma.j.issn.1007-3418.2017.08.007. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29056008 Clinical Trial. Chinese.
[Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].
Miao L, Yang WN, Dong XQ, Zhang ZQ, Xie SB, Zhang DZ, Zhang XQ, Cheng J, Zhang G, Zhao WF, Xie Q, Liu YX, Ma AL, Li J, Shang J, Bai L, Cao LH, Zou ZQ, Li JB, Lyu FD, Liu H, Wang ZJ, Zhang MX, Chen LM, Liang WF, Gao H, Zhuang H, Zhao H, Wang GQ. Miao L, et al. Among authors: zhang dz, zhang zq, zhang mx, zhang xq, zhang g. Zhonghua Gan Zang Bing Za Zhi. 2019 Jul 20;27(7):521-526. doi: 10.3760/cma.j.issn.1007-3418.2019.07.009. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31357778 Clinical Trial. Chinese.
[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection].
Gao YH, Li GM, Jin QL, Zhao YR, Jia ZS, Mao XR, Yang YF, Shang J, Wang GC, Xie W, Wu SM, Zhang MX, Hou JL, Li DL, Nan YM, Guan YJ, Zhu CX, Yuan YZ, Wei L. Gao YH, et al. Among authors: zhang mx. Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):352-357. doi: 10.3760/cma.j.issn.1007-3418.2019.05.006. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31177659 Clinical Trial. Chinese.
728 results